Standout Papers
Citation Impact
Citing Papers
Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93
2005
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
2018 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Whether to determine HER2 status for breast cancer in the primary tumour or in the metastasis.
2009
The measurement and therapeutic implications of circulating tumour cells in breast cancer
2005
HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
2010
Breast cancer
2019 Standout
Is gene array testing to be considered routine now?
2011
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer
2007
Gastric cancer
2016 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Dissecting the metastatic cascade
2004
Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer
2005
Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI
2012
Aortic dissection in pregnancy: analysis of risk factors and outcome
2003
Breast cancer
2016 Standout
Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
2010
Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging
2007 Standout
Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
2013
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Cancer Metastasis: Building a Framework
2006 Standout
External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score
2008
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Multiple Sclerosis: Low-Frequency Temporal Blood Oxygen Level–Dependent Fluctuations Indicate Reduced Functional Connectivity—Initial Results
2002
Plasticity of disseminating cancer cells in patients with epithelial malignancies
2012
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Laparoscopic Photodynamic Diagnosis of Ovarian Cancer Using 5-Aminolevulinic Acid in a Rat Model
2002
Significance, detection and markers of disseminated breast cancer cells
2006
Tumor metastasis: moving new biological insights into the clinic
2013
Environment-mediated drug resistance: a major contributor to minimal residual disease
2009
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
Target cell movement in tumor and cardiovascular diseases based on the epithelial–mesenchymal transition concept
2011
Current trends and emerging future of indocyanine green usage in surgery and oncology
2011
Validation of a Nomogram to Predict the Risk of Nonsentinel Lymph Node Metastases in Breast Cancer Patients with a Positive Sentinel Node Biopsy: Validation of the MSKCC Breast Nomogram
2009
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Role of bisphosphonates in postmenopausal women with breast cancer
2013
Cancer micrometastases
2009
Emerging Biological Principles of Metastasis
2017 Standout
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
2015
EMT: 2016
2016 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
TGFβ in Cancer
2008 Standout
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
2011
Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer
2014
The basics of epithelial-mesenchymal transition
2009 Standout
A Systematic Review of Oncoplastic Breast-Conserving Surgery
2013
A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma
2012
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
MRI for breast cancer screening, diagnosis, and treatment
2011
The follow-up of ovarian cancer
2003
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial
2000
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Epithelial–mesenchymal transitions in development and pathologies
2003
Breast cancer metastasis: markers and models
2005 Standout
Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments
2018
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study
2009
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Gynecologic Laparoscopy
2001
Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management
2008
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Targeted therapies in control of EMT in carcinoma and fibrosis
2007
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Breast Cancer Treatment
2019 Standout
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Oncoplastic breast conserving surgery.
2013
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer
2006
Works of Claude Nos being referenced
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
2003
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
2007
Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy
1998
Role of Dynamic Magnetic Resonance Imaging in the Evaluation of Tumor Response to Preoperative Concurrent Radiochemotherapy for Large Breast Cancers: A Prospective Phase II Study
2007
Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery
2010 Standout
Real‐time quantitative PCR determination of urokinase‐type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients
2004
Oncoplastic Techniques Allow Extensive Resections for Breast-Conserving Therapy of Breast Carcinomas
2003
Impact of Internal Mammary Sentinel Node Imaging in Breast Cancer
2003
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
2004
Blue Dye Injection in the Arm in Order to Conserve the Lymphatic Drainage of the Arm in Breast Cancer Patients Requiring an Axillary Dissection
2007
Second Look for Ovarian Cancer: Laparoscopy or Laparotomy? A Prospective Comparative Study
1999
Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy
2004
MRI for Surgical Planning in Patients with Breast Cancer Who Undergo Preoperative Chemotherapy
2004
Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse
2008
Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age
2004
[Acute aortic dissection during pregnancy. Surgical treatment with maternal and fetal rescue].
1993
Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients
2004
Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases
2003
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.
2000
Combined Axillary Reverse Mapping (ARM) Technique for Breast Cancer Patients Requiring Axillary Dissection
2008
Micrometastases in Sentinel Lymph Node in a Multicentric Study: Predictive Factors of Nonsentinel Lymph Node Involvement—Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer
2006